Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viekirax and Exviera effect on AMH in women with HCV
NCT02950870Phase 4Unknown
- Sponsor
- University of Modena and Reggio Emilia
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of paritaprevir and dasabuvir in hepatitis C virus infection, sponsored by University of Modena and Reggio Emilia. Status: unknown.
02
Drugs
paritaprevirdasabuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02950870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02950870.